Emil D. Kakkis, President & CEO at Ultragenyx Pharmaceutical Inc. (RARE), sold 95,706 shares at $33.52 ($3.2M) on 2023-10-19, disclosed to the SEC on 2023-10-23.
Seasonal sale ($3.2M) by President & CEO — this insider has traded RARE in October in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.52 | 47,853 | $1.6M | 50.0% |
| 2 | $33.52 | 47,853 | $1.6M | 50.0% |
| Total | $33.52 avg | 95,706 | $3.2M | 100% |
| Filing → |
| RARE | SELL | 2024-12-31 | $990K | — | Filing → |
| RARE | SELL | 2024-12-11 | $414K | — | Filing → |
| RARE | SELL | 2024-09-05 | $1.1M | — | Filing → |